# Phio Pharmaceuticals Corp.: Form DEF 14A, filed Mar 7, 2016

- Company: [Phio Pharmaceuticals Corp.](/companies/phio.md) (CIK 1533040)
- Form: DEF 14A
- Filed: 2016-03-07
- Accepted by EDGAR: Mar 7, 2016, 17:20 ET
- Period: 2016-04-14
- Accession: 0001193125-16-495425
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1533040/000119312516495425/d291334ddef14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1533040/000119312516495425/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1533040/000119312516495425/d291334ddef14a.htm

Filed Mar 7, 2016.
Source: SEC EDGAR, the filing index for accession 0001193125-16-495425. Last ingested by Listed: Nov 12, 2026, 20:44 ET. No prices; not investment advice.
